rs12522383
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_139281.3(WDR36):c.1904+448G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 151,914 control chromosomes in the GnomAD database, including 6,906 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 6906 hom., cov: 32)
Consequence
WDR36
NM_139281.3 intron
NM_139281.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.435
Publications
7 publications found
Genes affected
WDR36 (HGNC:30696): (WD repeat domain 36) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Mutations in this gene have been associated with adult-onset primary open-angle glaucoma (POAG). [provided by RefSeq, Jul 2008]
WDR36 Gene-Disease associations (from GenCC):
- glaucoma 1, open angle, GInheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WDR36 | ENST00000513710.4 | c.1904+448G>A | intron_variant | Intron 17 of 22 | 1 | NM_139281.3 | ENSP00000424628.3 |
Frequencies
GnomAD3 genomes AF: 0.295 AC: 44761AN: 151796Hom.: 6905 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
44761
AN:
151796
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.295 AC: 44768AN: 151914Hom.: 6906 Cov.: 32 AF XY: 0.300 AC XY: 22296AN XY: 74220 show subpopulations
GnomAD4 genome
AF:
AC:
44768
AN:
151914
Hom.:
Cov.:
32
AF XY:
AC XY:
22296
AN XY:
74220
show subpopulations
African (AFR)
AF:
AC:
9050
AN:
41440
American (AMR)
AF:
AC:
5070
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1332
AN:
3462
East Asian (EAS)
AF:
AC:
1306
AN:
5148
South Asian (SAS)
AF:
AC:
1900
AN:
4826
European-Finnish (FIN)
AF:
AC:
4294
AN:
10526
Middle Eastern (MID)
AF:
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20810
AN:
67934
Other (OTH)
AF:
AC:
647
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1588
3175
4763
6350
7938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1045
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.